These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1438917)

  • 21. Antibiotic susceptibility profiles of 941 gram-negative bacteria isolated from septicemic patients throughout Canada. The Canadian Study Group.
    Chamberland S; L'Ecuyer J; Lessard C; Bernier M; Provencher P; Bergeron MG
    Clin Infect Dis; 1992 Oct; 15(4):615-28. PubMed ID: 1420674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacodynamic effects of antibiotics. Studies on bacterial morphology, initial killing, postantibiotic effect and effective regrowth time.
    Hanberger H
    Scand J Infect Dis Suppl; 1992; 81():1-52. PubMed ID: 1322561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative activity of meropenem and other antibiotics against the pathogens of nosocomial infections].
    Sidorenko SV; Rezvan SP; Grudinina SA; Sterkhova GV; Aleksandrova IA
    Antibiot Khimioter; 1998; 43(1):4-14. PubMed ID: 9532326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative efficacy of fluoroquinolones, aminoglycosides, ureidopenicillins & newer cephalosporins against Pseudomonas species.
    Paul K; De PK; Bhattacharya S
    Indian J Med Res; 1992 May; 95():136-8. PubMed ID: 1506063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multilaboratory evaluation of the in vitro activity of 13 beta-lactam antibiotics against 1474 clinical isolates of aerobic and anaerobic bacteria.
    Murray PR; Jones RN; Allen SD; Erwin ME; Fuchs PC; Gerlach EH
    Diagn Microbiol Infect Dis; 1993; 16(3):191-203. PubMed ID: 8477573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydrolysis of imipenem, meropenem, ceftazidime, and cefepime by multiresistant nosocomial strains of Sphingobacterium multivorum.
    Blahová J; Králiková K; Krcméry V; Kubonová K
    Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):178-80. PubMed ID: 9105852
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative in vitro activity ampicillin, cefoperazone, their combinations with sulbactam, as well as that of other antibiotics against aerobic gram-negative microorganisms].
    Sidorenko SV; Rezvan SP; Speranskaia ON; Krotova LA; Tikhonova AS; Strachunskiĭ LS; Navashin SM; Kuleshov SE; Budanov SV; Ansolis LE
    Antibiot Khimioter; 1994 Nov; 39(11):10-20. PubMed ID: 7733770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bactericidal activity of cefpirome (HR 810) against 513 gram-negative bacteria isolated from blood of septicemic patients.
    Bergeron MG; Bernier M
    Infection; 1994; 22(4):299-305. PubMed ID: 8002094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The in vitro activity of flomoxef compared to four other cephalosporins and imipenem.
    Shah PM; Knothe H
    Infection; 1991; 19 Suppl 5():S279-83. PubMed ID: 1783444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aminoglycoside resistance. Enzymatic mechanisms in clinical bacterial strains in Slovakia during the last decade.
    Kallová J; Kettner M; Macicková T; Milosovic P; Langsádl L
    FEMS Immunol Med Microbiol; 1997 Sep; 19(1):89-94. PubMed ID: 9322073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-vitro activity of cefotetan and other cephalosporins against multiresistant strains of Enterobacteriaceae.
    Leigh DA; Marriner J
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():103-5. PubMed ID: 6573310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-vitro and in-vivo activity of DWC-751, a new cephalosporin.
    Choi KH; Kim DJ; Shim JS; Choi MJ; Park NJ; Kim BO; Yu YH; Choi EC
    J Antimicrob Chemother; 1994 Jun; 33(6):1233-7. PubMed ID: 7646611
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative in vitro activity of ciprofloxacin and other antimicrobial agents against aminoglycoside-resistant gram-negative rods and microorganisms isolated from patients with bacteremia.
    Weinstein MP
    Chemotherapy; 1986; 32(5):446-52. PubMed ID: 3757586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of multi-resistant gram-negative isolates in eight Dutch hospitals. The 1990 Dutch Surveillance Study.
    Buirma RJ; Horrevorts AM; Wagenvoort JH
    Scand J Infect Dis Suppl; 1991; 78():35-44. PubMed ID: 1947821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sensitivity of Pseudomonas to currently used antibacterial drugs].
    Antonov IuV; Iliukhin VI; Popovtseva LD; Batmanov VP
    Antibiot Khimioter; 1991 Jan; 36(1):14-6. PubMed ID: 2053815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents.
    Glupczynski Y; Hansen W; Freney J; Yourassowsky E
    Antimicrob Agents Chemother; 1988 Feb; 32(2):276-8. PubMed ID: 3163242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A survey of the sensitivity of fresh clinical isolates to cefuroxime and other antibiotics.
    Potaschmacher LO; Dash CH; Jefferson KA; Kennedy MR
    J Clin Pathol; 1979 Sep; 32(9):944-50. PubMed ID: 512055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility of Bordetella pertussis to cephalosporin derivatives and imipenem.
    Bannatyne RM; Cheung R
    Antimicrob Agents Chemother; 1984 Oct; 26(4):604-5. PubMed ID: 6097171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative characterization of the sensitivity of regional strains of various microorganisms to cefuroxime and other antibiotics].
    Veselov AIa; Osokina OV
    Antibiot Khimioter; 1996; 41(10):32-4. PubMed ID: 9027292
    [No Abstract]   [Full Text] [Related]  

  • 40. Epidemiology, control and treatment of multiresistant gram-negative rods.
    Wiedemann B
    Drugs; 1996; 52 Suppl 2():95-100; discussion 100-2. PubMed ID: 8869845
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.